Page last updated: 2024-08-23

desogestrel and Thromboembolism

desogestrel has been researched along with Thromboembolism in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (5.66)	18.7374
1990's	38 (71.70)	18.2507
2000's	10 (18.87)	29.6817
2010's	2 (3.77)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y	1
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M	1
Ishak, R	1
Bromham, DR	1
Killick, S	1
Comp, PC	1
Ory, HW	1
Westhoff, CL	1
Fabris, F; Girolami, A; Girolami, B; Spiezia, L; Vianello, F	1
Goldzieher, JW; Shulman, LP	1
Iversen, OE	1
Jick, H; Jick, SS; Kaye, JA; Russmann, S	1
Azevedo, GD; Ferriani, RA; Garcia, AA; Gomes, MK; Pintão, MC; Silva-de-Sá, MF; Vieira, CS	1
Davie, J; Glasier, A; Graham, A; Grieve, F	1
Weiss, N	1
Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C	1
Carnall, D; Josefson, D; Karcher, H; Lie, LG; Sheldon, T; Spurgeon, D; Zinn, C	1
Donnelly, RJ	1
Bromham, DR; Elias, J; Fotherby, K; Guillebaud, J; Kubba, A; Mills, AM; Wade, A; Wilkinson, CL	1
Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO; Thorogood, M	1
Cramer, DW	1
Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY	1
Lauritzen, C	1
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO	2
Collet, W; Hölscher, T; Schindler, AE; Schulte, H; Winkler, UH; Zierleyn, JP	1
Griffin, JP	1
Farmer, RD; Hambleton, IR; Kennedy, JG; Lawrenson, RA; Thompson, CR	1
Roke, C	1
Lidegaard, O	1
Brockmeier, J; Carlsson, J; Meierhenrich, R; Miketic, S; Obergassel, L; Sorges, E; Tebbe, U	1
Bergman, U; Daling, J; Grimes, D; Mills, A; Palmer, JR; Rosenberg, L; Sands, MI	1
Walker, AM	1
Weiss, G	1
Herings, RM; Leufkens, HG; Urquhart, J	1
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG	1
Skegg, DC	1
Meurer, LN; Slawson, JG	1
Dulícek, P	1
Milsom, I; Odlind, V; Ostlund, I; Persson, E; von Schoultz, B	1
Black, C; Jick, H; Kaye, JA	1
Bonnar, J; Sabra, AM	1
Bonnar, J	1
Amedeo, M; Crivello, T; Ferraris, G; Petrelli, P; Porcelli, A; Surico, N	1

Reviews

6 review(s) available for desogestrel and Thromboembolism

Article	Year
The truth about oral contraceptives and venous thromboembolism. The Journal of reproductive medicine, 2003, Volume: 48, Issue:11 Suppl Topics: Androstenes; Bias; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Risk Factors; Thromboembolism; Time Factors; Venous Thrombosis; Women's Health	2003
[Third-generation oral contraceptives--how big is the risk of venous thrombosis?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004, Jun-03, Volume: 124, Issue:11 Topics: Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Meta-Analysis as Topic; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis	2004
Comments on desogestrel and gestoden (3rd generation progestogens) and the incidence of thromboembolism. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:5 Topics: Adult; Desogestrel; Female; Humans; Incidence; Norpregnenes; Progesterone Congeners; Thromboembolism	1996
Modern oral contraceptives and cardiovascular disease. American journal of obstetrics and gynecology, 1997, Volume: 177, Issue:3 Topics: Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Myocardial Infarction; Norpregnenes; Risk Factors; Thromboembolism; United States; United States Department of Agriculture; World Health Organization	1997
Newer oral contraceptives and the risk of venous thromboembolism. Contraception, 1998, Volume: 57, Issue:3 Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; World Health Organization	1998
[Hormonal contraception and thromboembolic disease--pathophysiologic findings and practical recommendations]. Ceska gynekologie, 2001, Volume: 66, Issue:5 Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Hemostasis; Humans; Levonorgestrel; Progestins; Thromboembolism	2001

Trials

4 trial(s) available for desogestrel and Thromboembolism

Article	Year
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ (Clinical research ed.), 1996, Jan-13, Volume: 312, Issue:7023 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Germany; Humans; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; United Kingdom	1996
Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1996, Volume: 10, Issue:4 Topics: Adolescent; Adult; Blood Coagulation Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Estradiol Congeners; Ethinyl Estradiol; Female; Fibrin; Hemostasis; Humans; Middle Aged; Prospective Studies; Thromboembolism	1996
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet (London, England), 1999, Dec-11, Volume: 354, Issue:9195 Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism	1999
[Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism]. Minerva ginecologica, 1988, Volume: 40, Issue:9 Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism	1988

Other Studies

43 other study(ies) available for desogestrel and Thromboembolism

Article	Year
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. PloS one, 2017, Volume: 12, Issue:7 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult	2017
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception, 2013, Volume: 87, Issue:1 Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult	2013
Oral contraceptive pills and the risk of venous thromboembolism. Progress in human reproduction research, 1996, Issue:39 Topics: Biology; Cardiovascular System; Case-Control Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Developing Countries; Disease; Embolism; Europe; Family Planning Services; Physiology; Research; Risk Factors; Thromboembolism; Vascular Diseases	1996
German court lifts OC prescription ban. Contraceptive technology update, 1998, Volume: 19, Issue:3 Topics: Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Germany; Jurisprudence; North America; Thromboembolism; United States; Vascular Diseases	1998
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit. Malaysian journal of reproductive health : a publication of the Reproductive Research Centre of the National Population and Family Development Board, Malaysia, 1991, Volume: 9, Issue:1 Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases	1991
Pill research results in new guidance from CSM. Family planning today, 1995 Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases	1995
Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts? Contraception Report, 1996, Volume: 7, Issue:1 Topics: Americas; Bias; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Government Agencies; North America; Organizations; Research; Research Design; Thromboembolism; United Kingdom; United States; United States Food and Drug Administration; United States Public Health Service; Vascular Diseases	1996
Oral contraceptives and venous thromboembolism: consensus conference statement. Dialogues in contraception, 1996,Spring Topics: Americas; Bias; Congresses as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Family Planning Services; North America; Research; Research Design; Thromboembolism; United States; Vascular Diseases	1996
Another pill scare -- should we audit its impact? Audit Unit News, 1996, Volume: 1, Issue:4 Topics: Abortion, Induced; Behavior; Communication; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Developed Countries; Disease; Embolism; Emotions; Europe; Evaluation Studies as Topic; Family Planning Services; Fear; Health Planning; Mass Media; Program Evaluation; Psychology; Thromboembolism; United Kingdom; Vascular Diseases	1996
Don't be scared. Audit Unit News, 1996, Volume: 1, Issue:4 Topics: Behavior; Communication; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Emotions; Europe; Family Planning Services; Fear; Health Planning; Mass Media; Organization and Administration; Program Evaluation; Psychology; Thromboembolism; United Kingdom; Vascular Diseases	1996
Coagulation and thrombosis with OC use: physiology and clinical relevance. Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1 Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Disease; Embolism; Family Planning Services; Physiology; Risk Factors; Thromboembolism; Vascular Diseases	1996
Epidemiology of venous thromboembolic disease and OC use. Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1 Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases	1996
A perspective on the concept of "risk". Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1 Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Disease; Embolism; Family Planning Services; Risk Factors; Thromboembolism; Vascular Diseases	1996
2 methods for prescribing third-generation OCs. Contraceptive technology update, 1997, Volume: 18, Issue:12 Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases	1997
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs. Contraceptive technology update, 1997, Volume: 18, Issue:12 Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases	1997
Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2003, Volume: 9, Issue:2 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Humans; Incidence; Italy; Middle Aged; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis	2003
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception, 2006, Volume: 73, Issue:6 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism	2006
Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Human reproduction (Oxford, England), 2007, Volume: 22, Issue:8 Topics: Adult; alpha-2-Antiplasmin; Antithrombins; Blood Coagulation; Desogestrel; Drug Implants; Female; Fibrin Fibrinogen Degradation Products; Humans; Prospective Studies; Protein C; Protein S; Thromboembolism; Venous Thrombosis	2007
Oral contraceptives and venous thromboembolism. Lancet (London, England), 1995, Nov-25, Volume: 346, Issue:8987 Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Thromboembolism	1995
Third-generation oral contraceptives: how risky? Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norpregnenes; Risk Factors; Thromboembolism	1995
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors	1995
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism	1995
Third generation oral contraceptives--the controversy. BMJ (Clinical research ed.), 1995, Dec-16, Volume: 311, Issue:7020 Topics: Attitude to Health; Australia; Canada; Contraceptives, Oral, Synthetic; Desogestrel; Female; Germany; Humans; Mass Media; Netherlands; Norpregnenes; Norway; Thromboembolism; United Kingdom; United States	1995
Scare over oral contraceptives. Studies implicate only gestodene and desogestrel. BMJ (Clinical research ed.), 1995, Dec-16, Volume: 311, Issue:7020 Topics: Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Thromboembolism	1995
Guidelines for prescribing combined oral contraceptives. BMJ (Clinical research ed.), 1996, Jan-13, Volume: 312, Issue:7023 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Drug Prescriptions; Humans; Norpregnenes; Practice Guidelines as Topic; Risk; Thromboembolism	1996
Safety of combined oral contraceptive pills. Lancet (London, England), 1996, Feb-24, Volume: 347, Issue:9000 Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Thromboembolism; Thrombophlebitis	1996
Safety of combined oral contraceptive pills. Lancet (London, England), 1996, Feb-24, Volume: 347, Issue:9000 Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism	1996
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception, 1996, Volume: 54, Issue:1 Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism	1996
Desogestrel, gestodene contraceptives may carry greater thromboembolic risk. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Feb-01, Volume: 53, Issue:3 Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Thromboembolism	1996
Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis. Adverse drug reactions and toxicological reviews, 1996, Volume: 15, Issue:1 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Thromboembolism	1996
Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet (London, England), 1997, Jan-11, Volume: 349, Issue:9045 Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Population Surveillance; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophlebitis; United Kingdom	1997
Oral contraception and venous thromboembolism. A New Zealand perspective. Drug safety, 1997, Volume: 16, Issue:2 Topics: Bias; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; New Zealand; Odds Ratio; Risk Factors; Thromboembolism	1997
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Acta obstetricia et gynecologica Scandinavica, 1997, Volume: 76, Issue:3 Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism	1997
[Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?]. Medizinische Klinik (Munich, Germany : 1983), 1997, Jan-15, Volume: 92, Issue:1 Topics: Adult; Angiography; Contraceptives, Oral, Synthetic; Coronary Thrombosis; Desogestrel; Diagnosis, Differential; Echocardiography, Transesophageal; Ethinyl Estradiol; Female; Heart Septal Defects, Atrial; Humans; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombosis; Ulnar Artery	1997
Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism. BMJ (Clinical research ed.), 1997, Sep-13, Volume: 315, Issue:7109 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Myocardial Infarction; Norpregnenes; Risk Factors; Thromboembolism	1997
Risk of venous thromboembolism with third-generation oral contraceptives: A review. American journal of obstetrics and gynecology, 1999, Volume: 180, Issue:2 Pt 2 Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis	1999
Venous thromboembolism among new users of different oral contraceptives. Lancet (London, England), 1999, Jul-10, Volume: 354, Issue:9173 Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Middle Aged; Risk Factors; Thromboembolism	1999
Third generation oral contraceptives. BMJ (Clinical research ed.), 2000, Jul-22, Volume: 321, Issue:7255 Topics: Activated Protein C Resistance; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism	2000
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? The Journal of family practice, 2001, Volume: 50, Issue:2 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis	2001
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations]. Lakartidningen, 2002, Jan-10, Volume: 99, Issue:1-2 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Information Services; Drug Prescriptions; Female; Humans; Levonorgestrel; Practice Guidelines as Topic; Progestins; Risk Factors; Thromboembolism; Venous Thrombosis	2002
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. British journal of clinical pharmacology, 2002, Volume: 53, Issue:6 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis	2002
Oral contraceptives and blood coagulation. The Journal of reproductive medicine, 1986, Volume: 31, Issue:6 Suppl Topics: Age Factors; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor VII; Factor X; Female; Fibrinolysis; Humans; Norgestrel; Norpregnenes; Platelet Aggregation; Prothrombin; Thromboembolism	1986
Coagulation effects of oral contraception. American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2 Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis	1987